121/314US=23-D / Câncer
Higashi M, Tamada S, Nagata K, Goto M, Yonezawa S. Extrahepatic bile duct carcinoma: mucin 4, a poor prognostic factor. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 451-9. ISBN 978-1-4020-9803-1.

CARCINOMA DO DUCTO BILIAR EXTRA-HEPATICA


122/314US=23-D / Câncer
Wiedmann M, Mössner J, Witzigmann H. Hilar cholangiocarcinoma: photodynamic therapy and stenting. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 463-83. ISBN 978-1-4020-9803-1.

COLANGIOCARCINOMA HILAR; TERAPIA FOTODINAMICA; IMPLANTE DE STENT


123/314US=23-D / Câncer
Compérat E, Charlotte F. Splenic metastases: diagnosis methods. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 489-97. ISBN 978-1-4020-9803-1.

METASTASE ESPLENICA


124/314Câncer
Costa H, Lima FO,Barrezueta LFM, Oshima CTF, Silva Júnior JA, Gomes TS, Artigiani Neto R, Franco M. Correlation between immunoexpression of BCL-2 protein family with apoptosis index, cellular proliferation and survival in colorectal carcinomas. Applied Cancer Research, São Paulo: Tecmedd, v.31, n.3, p. 74-80, 2011. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR2011;31p.74-80.pdf

APOPTOSE; PROLIFERACAO CELULAR; NEOPLASIAS COLORRETAIS; ANALISIS MICROARRAIS; PROTEINA BCL2


125/314US=23 / Câncer
Hayat MA. Breast cancer: an introduction. In: ___. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 1-3. ISBN 978-1-4020-8368-6.

CANCER DE MAMA. INTRODUCAO


126/314US=23 / Câncer
Zheng B. Breast cancer: computer-aided detection. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 5-27. ISBN 978-1-4020-8368-6.

CANCER DE MAMA. DETECCAO; COMPUTADOR; CAD; DIAGNOSTICO AUXILIADO POR COMPUTADOR


127/314US=23 / Câncer
Hisaoka M, Hamada T. Sebaceous carcinoma of the breast: clinicopathologic features. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 29-32. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CARCINOMA SEBACEO DA MAMA; CARACTERISTICAS CLINICO-PATOLOGICAS


128/314US=23 / Câncer
Bach-Gansmo T, Tobin D. Breast cancer: detection by in-vivo imaging of angiogenesis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 33-42. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; ANGIOGENESE IN VIVO; INTEGRINAS; CINTILOGRAFIA; TC-NC100692; EXPERIENCIA CLINICA INICIAL; RAIOS GAMA; CAMARA GAMA


129/314US=23 / Câncer
Mattie MD, Getts RC. Breast and prostate biopsies: use of optimized high-throughput microRNA expression for diagnosis (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 43-59. ISBN 978-1-4020-8368-6.

CANCER DE MAMA. DIAGNOSTICO; BIOPSIAS; USO DE EXPRESSAO DE MICRORNA; METODOLOGIA


130/314US=23 / Câncer
Bult P, Hoogerbrugge N. Familial breast cancer: detection of prevalent high-risk epithelial lesions. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 61-71. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA FAMILIAR; CARCINOMA LOBULAR IN SITU; HIPERPLASIA LOBULAR ATIPICA; CARCINOMA DUCTAL IN SITU; HIPERPLASIA DUCTAL ATIPICA


131/314US=23 / Câncer
Tang APY, Tse GMK, Lam WWM. Differentiation between benign and malignant papillary lesions of breast: excisional biopsy or stereotactic vacuum-assisted biopsy (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 73-97. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; LESOES BENIGNAS PAPILARES DE MAMA; LESOES MALIGNAS PAPILARES DE MAMA; BIOPSIA EXCISIONAL; BIOPSIA VACUO-ASSISTIDA; BIOPSIA ASSISTIDA POR VACUO; CARCINOMA DUCTAL; ASPIRACAO POR AGULHA FINA; BIOPSIA POR AGULHA; BIOPSIA EXCISIONAL; ESTEREOTAXIA; ULTRASSOM


132/314US=23 / Câncer
Knauer M, Konstantiniuk P, Haid A, Wenzl E, Koberle-Wuhrer R, Riegler-Keil M, Postlberger S, Reitsamer R, Schrenk P. Multicentric breast cancer: sentinel node biopsy as a diagnostic tool. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 99-108. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA MULTICENTRICO; BIOPSIA DE LINFONODO SENTINELA


133/314US=23 / Câncer
Lumachi F, Basso SMM, Basso U. Breast cancer recurrence: role of serum tumor markers CEA and CA 15-3. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 109-15. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA RECORRENTE; PAPEL DO SORO; MARCADORES TUMORAIS; CEA; CA 15-3; ANTIGENO CARCINOEMBRIONARIO


134/314US=23 / Câncer
Zehentner BK. Breast cancer patients before, during or after treatment: circulating tumor cells in peripheral blood detected by multigene real-time reverse transcriptase-polymerase chain reaction. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 117-23. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CELULAS TUMORAIS CIRCULANTES; SANGUE PERIFERICO; REACAO MULTIGENICA EM TEMPO REAL; REACAO EM CADEIA DA POLIMERASE-TRANSCRIPTASE REVERSA


135/314US=23 / Câncer
Feng Q, Kiviat NB. Breast cancer patients: diagnostic epigenetic markers in blood. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 125-40. ISBN 978-1-4020-8368-6.

CANCER DE MAMA. DIAGNOSTICO; MARCADORES EPIGENETICOS NO SANGUE; ANALISE DE METILACAO; METILACAO-ESPECIFICA PCR; METODO DE REACAO EM CADEIA POR POLIMERASE; ANALISE DE DADOS


136/314US=23 / Câncer
Lin SR, Wang JY, Huang MY, Chen CC. Breast cancer patients: detection of circulating cancer cell-related mRNA markers with membrane array method. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 141-55. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; DETECCAO DE MARCADORES CIRCULANTES; METODO DE MATRIZ DE MRNA; METODO DE MATRIZ DE MEMBRANA; REACAO DA TRANSCRIPTASE REVERSA


137/314US=23 / Câncer
Yie SM. Prediction of metastasis and recurrence of breast carcinoma: detection of survivin-expressing circulating cancer cells. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 157-74. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; METASTASES; CARCINOMA DA MAMA; SURVIVINA; REACAO EM CADEIA DE POLIMERASE; METODOLOGIA ELISA


138/314US=23 / Câncer
Xenidis N, Perrakis M, Kakolyris S, Mavroudis D, Georgoulias V. Node-negative breast cancer: predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 175-88. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CITOQUERATINA-19-MRNA POSITIVOS; CELULAS TUMORAIS CIRCULANTES


139/314US=23 / Câncer
Bianco C, Strizzi L, De Luca A, Normanno N, Salomon DS. Breast and colon carcinomas: detection with plasma CRIPTO-1. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 189-202. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CARCINOMAS DE MAMA; CARCINOMA DE COLON; PLASMA CRIPTO-1; TUMORIGENESE; ELISA


140/314US=23 / Câncer
Baltzell K, Mills D, Ljung BM, Love S, Wrensch M. Breast cancer risk in women with abnormal cytology in nipple aspirate fluid. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 203-16. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CITOLOGIA ANORMAL; FLUIDO ASPIRADO; AVALIACAO DE RISCO; DUCTO MAMARIO. ANATOMIA; FLUIDO DO ASPIRADO DE MAMILO; NAF


Primeira | Anterior | Próxima | Última